Adaptive Biotechnologies (ADPT) Change in Acquisitions & Divestments (2018 - 2026)

Adaptive Biotechnologies has disclosed Change in Acquisitions & Divestments across 9 years of filings, most recently posting $48.8 million for Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at $48.8 million, down 37.02% year-over-year; the trailing twelve-month figure through Mar 2026 was $193.9 million (down 36.14% YoY), and the FY2025 annual result was $222.6 million, down 31.65% from the prior year.
• Change in Acquisitions & Divestments came in at $48.8 million for Q1 2026 at Adaptive Biotechnologies, up from $39.1 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $155.0 million in Q1 2023 to a low of $35.0 million in Q2 2022.
• The 5-year median for Change in Acquisitions & Divestments is $77.5 million (2025), against an average of $86.2 million.
• Across the five-year window, Change in Acquisitions & Divestments sank 75.78% in 2022 and soared 301.15% in 2023, its largest moves.
• Adaptive Biotechnologies' Change in Acquisitions & Divestments stood at $70.0 million in 2022, then soared by 80.63% to $126.5 million in 2023, then slumped by 47.04% to $67.0 million in 2024, then slumped by 41.62% to $39.1 million in 2025, then climbed by 24.77% to $48.8 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $48.8 million (Q1 2026), $39.1 million (Q4 2025), and $50.9 million (Q3 2025), per Business Quant data.